| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.001 | 1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |